findmyKOL
Clinical trialNCT02477748TerminatedPhase 3Interventional

The MEASURE Study - A Phase 3 Study of MDX 1400 mg Daily Compared With Placebo in Adults With ADHD

SponsorAlcobra Ltd.Enrollment283Attention Deficit Hyperactivity Disorder (ADHD)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Rambam Medical Center

    Haifa, Israel

  • Geha Medical Centre

    Petah Tikva, Israel

United States
  • Harmonex, Inc.

    Dothan, Alabama, United States

  • Pharmacology Research Institute

    Los Alamitos, California, United States

  • Pharmacology Research Institute

    Newport Beach, California, United States

  • Artemis Institute for Clinical Research

    San Diego, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Mcb Clinical Research Centers

    Colorado Springs, Colorado, United States

  • Connecticut Clinical Research

    Cromwell, Connecticut, United States

  • Coastal Connecticut Research

    New London, Connecticut, United States

  • Sarkis Clinical Trials

    Gainesville, Florida, United States

  • Clinical Neuroscience Solutions

    Jacksonville, Florida, United States

  • Cns Healthcare

    Orlando, Florida, United States

  • Miami Research Associates

    South Miami, Florida, United States

  • Institute for Advanced Medical Research

    Alpharetta, Georgia, United States

  • Goldpoint Clinical Research

    Indianapolis, Indiana, United States

  • Lake Charles Clinical Trials

    Lake Charles, Louisiana, United States

  • Kennedy Krieger Institute

    Baltimore, Maryland, United States

  • Rochester Center for Behavioral Medicine

    Rochester Hills, Michigan, United States

  • St. Charles Psychiatric Associates - Midwest Research Group

    Saint Charles, Missouri, United States

  • Premier Psychiatric Research Institute

    Lincoln, Nebraska, United States

  • Center for Emotional Fitness

    Cherry Hill, New Jersey, United States

  • Global Medical Institutes, Llc, Princeton Medical Institute

    Princeton, New Jersey, United States

  • the Medical Research Network

    New York, New York, United States

  • Richard H Weisler, Md, Pa

    Raleigh, North Carolina, United States

  • Neuro-Behavioral Clinical Research, Inc.

    Canton, Ohio, United States

  • Ips Research Company

    Oklahoma City, Oklahoma, United States

  • Village Clinical Research Inc

    Oklahoma City, Oklahoma, United States

  • Summit Research Network

    Portland, Oregon, United States

  • Suburban Research Associates

    Media, Pennsylvania, United States

  • Carolina Clinical Research, Inc.

    Charleston, South Carolina, United States

  • Clinical Neuroscience Solutions

    Memphis, Tennessee, United States

  • Biobehavioral Research of Austin at Specialty Clinic of Austin

    Austin, Texas, United States

  • Bayou City Research

    Houston, Texas, United States

  • Psychiatric & Behavioral Solutions

    Salt Lake City, Utah, United States

  • Neuroscience, Inc. (nsi)

    Herndon, Virginia, United States

  • Summit Research Network(seattle)llc

    Seattle, Washington, United States

  • Dean Foundation - Middleton

    Middleton, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2015
Primary completion
31 Jan 2017
Completion
31 Jan 2017
Last update posted
19 Jan 2017
Registered enrollment
283
Registry id
NCT02477748

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.